ZA745305B - Improvements relating to pyrimidines - Google Patents

Improvements relating to pyrimidines

Info

Publication number
ZA745305B
ZA745305B ZA00745305A ZA745305A ZA745305B ZA 745305 B ZA745305 B ZA 745305B ZA 00745305 A ZA00745305 A ZA 00745305A ZA 745305 A ZA745305 A ZA 745305A ZA 745305 B ZA745305 B ZA 745305B
Authority
ZA
South Africa
Prior art keywords
pyrimidines
improvements relating
relating
Prior art date
Application number
ZA00745305A
Inventor
E Muller
W Haarmann
B Narr
J Roch
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA745305B publication Critical patent/ZA745305B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63C—SKATES; SKIS; ROLLER SKATES; DESIGN OR LAYOUT OF COURTS, RINKS OR THE LIKE
    • A63C19/00—Design or layout of playing courts, rinks, bowling greens or areas for water-skiing; Covers therefor
    • A63C19/02—Shaping of the surface of courts according to the necessities of the different games

Landscapes

  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00745305A 1973-08-20 1974-08-19 Improvements relating to pyrimidines ZA745305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732341925 DE2341925A1 (en) 1973-08-20 1973-08-20 2,4, (opt.5-), 6-substd. pyriminidines as antithrombic agents - e.g. 6-methyl-5-nitro-2-piperazino-4-thiomorpolino-pyrimidine

Publications (1)

Publication Number Publication Date
ZA745305B true ZA745305B (en) 1976-04-28

Family

ID=5890167

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00745305A ZA745305B (en) 1973-08-20 1974-08-19 Improvements relating to pyrimidines

Country Status (4)

Country Link
JP (1) JPS5049288A (en)
BE (1) BE818990A (en)
DE (1) DE2341925A1 (en)
ZA (1) ZA745305B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172255A (en) * 1980-12-11 1984-08-07 Robert R. Covington Buspirone process
JPH0635450B2 (en) * 1984-03-16 1994-05-11 三井東圧化学株式会社 Thiocyanopyrimidine derivative, its production method and agricultural / horticultural fungicide
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
US5075305A (en) * 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
US5658923A (en) * 1992-09-18 1997-08-19 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives and use thereof
ES2146614T3 (en) * 1992-09-18 2000-08-16 Asahi Chemical Ind DERIVATIVES OF AZEPINA, PRODUCTION OF THE SAME AND ITS USE AS LIGANDS OF THE SIGMA RECEIVER.
CA2208900C (en) * 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
IL137922A0 (en) 1998-02-17 2001-10-31 Tularik Inc Anti-viral pyrimidine derivatives
US6410726B1 (en) 2000-01-12 2002-06-25 Tularik Inc. Arylsulfonic acid salts of pyrimidine-based antiviral
ES2375111T3 (en) 2002-11-21 2012-02-24 Novartis Ag PYRIMIDINES 2,4,6-TRISUSTITUIDAS AS INHIBITORS OF FOSFOTIDILINOSITOL (PI) 3-QUINASA AND ITS USE IN THE TREATMENT OF C�? NCER.
NZ540612A (en) * 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
EP1927594A1 (en) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
TW200519094A (en) 2003-07-02 2005-06-16 Vertex Pharma Pyrimidines useful as modulators of voltage-gated ion channels
AR045047A1 (en) 2003-07-11 2005-10-12 Arena Pharm Inc ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
WO2005011655A2 (en) 2003-07-30 2005-02-10 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
ATE532772T1 (en) 2003-07-30 2011-11-15 Xenon Pharmaceuticals Inc PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
HUP0400405A3 (en) * 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
JP2007217282A (en) * 2004-03-04 2007-08-30 Astellas Pharma Inc Substituted pyrimidine derivative
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006034341A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
CA2580787A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
EP1799668A1 (en) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
BRPI0515488A (en) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc heterocyclic derivatives and their use as therapeutic agents
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
JP4958786B2 (en) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド Heterocyclic derivatives and their use as therapeutic agents
DOP2006000010A (en) 2005-01-10 2006-07-31 Arena Pharm Inc PROCEDURE TO PREPARE AROMATIC ETERES
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP1904491A2 (en) 2005-05-31 2008-04-02 Vertex Pharmaceuticals Incorporated Heterocycles useful as modulators of ion channels
BRPI0611187A2 (en) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc amino thiazide derivatives as inhibitors of human stearoyl coa desaturase
GB0512844D0 (en) * 2005-06-23 2005-08-03 Novartis Ag Organic compounds
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي PI-3 Kinase inhibitors and methods of their use
CA2675558A1 (en) 2007-02-06 2008-08-14 Novartis Ag Pi 3-kinase inhibitors and methods of their use
WO2009038974A1 (en) 2007-09-20 2009-03-26 Irm Llc Compounds and compositions as modulators of gpr119 activity
KR20110002465A (en) * 2008-03-31 2011-01-07 젠야쿠코교가부시키가이샤 Pyrimidine derivative having cell protecting effect and uses thereof
ES2623794T3 (en) * 2008-12-09 2017-07-12 Gilead Sciences, Inc. Intermediates for the preparation of toll receptor modulators
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP2771337B1 (en) 2011-09-27 2017-08-02 Novartis AG 3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh
CN103204816B (en) 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 Piperazinylpyrimidine analog derivative and its production and use
UY34632A (en) 2012-02-24 2013-05-31 Novartis Ag OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
EP2970240B1 (en) 2013-03-14 2018-01-10 Novartis AG 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
EP4445956A2 (en) 2015-01-06 2024-10-16 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
WO2016209809A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Also Published As

Publication number Publication date
BE818990A (en) 1975-02-19
JPS5049288A (en) 1975-05-01
DE2341925A1 (en) 1975-03-06

Similar Documents

Publication Publication Date Title
ZA745305B (en) Improvements relating to pyrimidines
ZA742415B (en) Improvements relating to knef arthroplasty
ZA743933B (en) Improvements relating to fasteners
ZA742939B (en) Improvements in or relating to burners
ZA74145B (en) Improvements relating to burners
HK32180A (en) Improvements relating to electrothernal printers
ZA742816B (en) Improvements relating to substituted butyrophenones
IL44884A0 (en) Improvements relating to buildings
ZA74116B (en) Improvements relating to housings
ZA74773B (en) Improvements in or relating to wiretinning systems
ZA744314B (en) Improvements in or relating to cephalosporin compounds
ZA741173B (en) Improvements relating to substituted 2-phenylamino-imidazolines-(2)
ZA742137B (en) Improvements relating to ventilators
ZA741309B (en) Improvements in or relating to packagung
AU7259074A (en) Pyrimidine derivatives
ZA744512B (en) Novel benzyl pyrimidines
ZA741301B (en) Improvements relating to 1-aryloxy-2-hydroxy-3-alkinylaminopropanes
ZA745267B (en) Improvements relating to 1-(m-acyloxyphenyl)-hydroxy-2-n-alkylamino-ethanes
HK58377A (en) Improvements in or relating to cine-film cameras
ZA741459B (en) Improvements relating to ventilators
ZA746470B (en) Substituted uracils
ZA738006B (en) Improvements in or relating to woolgrease
JPS5149961A (en) tateamiki no shujiku to garaseigyosochi no dokihoho
ZA744904B (en) Improvements in or relating to cephalosporin compounds
HK17977A (en) Improvements in or relating to cameras